InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by LEE KENNETH B JR. Officer active across 2 companies, notably Eyenovia, INC.. Cumulatively, 9 disclosures have been logged. Total volume traded: €38k. The latest transaction was filed on 16 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations9 total
022,222 shares0
Common Stock, par value $.0001
SEC:0001415889-22-006807:0·
012,866 shares0
Common Stock
SEC:0001127602-22-017144:0·
€20,79610,000 shares@ €2.079654.1% of flow
Common Stock, par value $.0001
SEC:0001415889-22-005467:0·
Ideal exit: 13 Feb 2023 (T+270)
06,963 shares0
Common Stock, par value $.0001
SEC:0001415889-21-005357·
06,963 shares0
Common Stock, par value $.0001
SEC:0001415889-21-005357:0·
€40,89115,000 shares@ €2.72610.0025% mcap100.0% of flow
Common Stock
SEC:0001127602-21-025331·
€40,89115,000 shares@ €2.72610.0025% mcap50.0% of flow
Common Stock
SEC:0001127602-21-025331:0·
€8,8402,000 shares@ €4.4198100.0% of flow
Common Stock, par value $.0001
SEC:0001638599-21-000551·
Ideal exit: 8 Mar 2022 (T+270)
€8,8402,000 shares@ €4.419823.0% of flow
Common Stock, par value $.0001
SEC:0001638599-21-000551:0·
Ideal exit: 8 Mar 2022 (T+270)
9 of 9 declarations
About LEE KENNETH B JR
Kenneth B Jr Lee is a director at Eyenovia, INC. and is also associated with Biocryst Pharmaceuticals INC.
